Molecular features associated with long survival on tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial

Authors

M Orloff
Brendan Curti, ProvidenceFollow
See full list of authors in comments

Document Type

Abstract

Publication Date

11-1-2023

Keywords

oregon; chiles

Clinical Institute

Cancer

Department

Oncology

Comments

Orloff M, Kim K, Stanhope S, Benlahrech A, Leach E, Collins L, Ranade K, Curti B. SITC Annual Meeting; November 1-5; San Diego, CA. 2023;11(Suppl 1): 30.

Recommended Citation

Orloff, M; Curti, Brendan; and See full list of authors in comments, "Molecular features associated with long survival on tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial" (2023). Articles, Abstracts, and Reports. 8356.
https://digitalcommons.providence.org/publications/8356